AMEX:AEON (USA)
Â
Ordinary Shares - Class A
$
0.25
-0.0063 (-2.42%)
10:08 PM EST
Business Description
AEON Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : US00791X2099
Share Class Description:
AEON: Ordinary Shares - Class ATotal Employee Number:
8Description
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.38 | |||||
Equity-to-Asset | -1.94 | |||||
Debt-to-Equity | -0.16 | |||||
Debt-to-EBITDA | -0.14 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 78.2 | |||||
3-Year EPS without NRI Growth Rate | 61.2 | |||||
3-Year FCF Growth Rate | 75.4 | |||||
3-Year Book Growth Rate | 81.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 16.53 | |||||
9-Day RSI | 16.44 | |||||
14-Day RSI | 19.34 | |||||
3-1 Month Momentum % | -26.66 | |||||
6-1 Month Momentum % | -38.81 | |||||
12-1 Month Momentum % | -8.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.99 | |||||
Quick Ratio | 0.99 | |||||
Cash Ratio | 0.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -216.7 | |||||
Shareholder Yield % | -47.14 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -621.16 | |||||
ROIC % | -544.7 | |||||
3-Year ROIIC % | -47.32 | |||||
ROC (Joel Greenblatt) % | -1415.42 | |||||
ROCE % | -1036.61 | |||||
Years of Profitability over Past 10-Year | 2 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 0.02 | |||||
EV-to-EBIT | -0.41 | |||||
EV-to-Forward-EBIT | -3.26 | |||||
EV-to-EBITDA | -0.42 | |||||
EV-to-FCF | -0.63 | |||||
Earnings Yield (Greenblatt) % | -243.9 | |||||
FCF Yield % | -107.46 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:AEON
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AEON Biopharma Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -5 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 42.08 | ||
| 14-Day RSI | 19.34 | ||
| 14-Day ATR ($) | 0.047741 | ||
| 20-Day SMA ($) | 0.43548 | ||
| 12-1 Month Momentum % | -8.49 | ||
| 52-Week Range ($) | 0.2222 - 1.45 | ||
| Shares Outstanding (Mil) | 44.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AEON Biopharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AEON Biopharma Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 107 days | ||
| Second quarter earnings results for 2026 | 2026-08-12 | In 14 days | ||
| General meeting for 2026 | 2026-06-17 10:00 | 0.67 (-8.15%) | ||
| First quarter earnings results for 2026 | 2026-05-14 | 0.82 (-5.65%) | ||
| Annual report for 2025 | 2026-03-30 | 1.16 (+18.36%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-30 | 1.16 (+18.36%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 0.94 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-12 | 0.66 (-9.82%) | ||
| General meeting for 2025 | 2025-06-13 10:00 | 0.89 (-3.84%) | ||
| First quarter earnings results for 2025 | 2025-05-14 | 0.50 (+0.42%) |
Show
Entries
AEON Biopharma Inc Frequently Asked Questions
What is AEON Biopharma Inc(AEON)'s stock price today?
The current price of AEON is $0.25. The 52 week high of AEON is $1.45 and 52 week low is $0.22.
When is next earnings date of AEON Biopharma Inc(AEON)?
The next earnings date of AEON Biopharma Inc(AEON) is 2026-08-12 Est..
Does AEON Biopharma Inc(AEON) pay dividends? If so, how much?
AEON Biopharma Inc(AEON) does not pay dividend.
Guru Commentaries on AMEX:AEON
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Thinking about buying stock in Mullen Automotive, Traction Uranium, Aeon Biopharma, BigBear.ai Holdings, or Lumen Technologies? | 2023-08-30 |
Articles on AEON Biopharma Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers